Submit
Search
Submit
Menu

  • Information

  • References

  • Contents

  • [1]P Langer: Differences in the Composition of Colostrum and Milk in Eutherians Reflect Differences in Immunoglobulin Transfer. J Mammal 90 (2), 332-9 (2009)

  • [2]RL Shen, T Thymann, MV Østergaard, AC Støy, Ł Krych, DS Nielsen, C Lauridsen, B Hartmann, JJ Holst, DG Burrin, PT Sangild: Early gradual feeding with bovine colostrum improves gut function and NEC resistance relative to infant formula in preterm pigs. Am J Physiol Gastrointest Liver Physiol 309 (5), 310-23 (2015)

  • [3]B Lonnerdal: Bioactive proteins in breast milk. J Paediatr Child Health 49 (Suppl 1), 1-7 (2013)

  • [4]SI Kehoe, BM Jayarao, AJ Heinrichs: A survey of bovine colostrum composition and colostrum management pratictices on Pennsylvania diry farms. J Dairy Sci 90 (9), 4108-16 (2007)

  • [5]K Stelwagen, E Carpenter, B Haigh, A Hodgkinson, TT Wheeler: Immune components of bovine colostrum and milk. J Anim Sci 87 (Suppl 13), 3-9 (2009)

  • [6]KF Benson, SG Carter, KM Patterson, D Patel, GS Jensen: A novel extract from bovine colostrum whey supports anti-bacterial and anti-viral innate immune functions in vitro and in vivo I. Enhanced immune activity in vitro translates to improved microbial clearance in animal infection models. Prev Med 54, 116-23 (2011)

  • [7]RM Lawrence, CA Pane: Human breast milk: current concepts of immunology and infectious diseases. Curr Probl Pediatr Adolesc Health Care 37 (1), 7-37 (2007)

  • [8]TT Wheeler, AJ Hodgkinson, CG Prosser, SR Davis: Immune components of colostrums and milk: a historical perspective. J Mammary Gland Biol Neoplasia 12(4), 237-47 (2007)

  • [9]M Janusz, A Zabłocka: Colostrinin: a proline-rich polypeptide complex of potential therapeutic interest. Cell Mol Biol 59(1), 4-11 (2013)

  • [10]RJ Playford: Peptide therapy and the gastroenterologist: colostrum and milk-derived growth factors. Clin Nutr 20 (Suppl 1), 101-6 (2001)

  • [11]KS Kelly: Bovine colostrums: A review of clinical uses. Altern Med Rev 8(4), 378–94 (2004)

  • [12]H Li, RE Aluko: Bovine colostrum as a bioactive product against human microbial infections and gastrointestinal disorders. Curr Top Nutraceutical Res 4(3-4), 227-37 (2006)

  • [13]L Elfstrand, H Lindmark-Månsson, M Paulssona, L Nybergc, B Akesson: Immunoglobulins, growth factors and growth hormone in bovine colostrum and the effects of processing. Int Dairy J 12(11), 879-87 (2002)

  • [14]M Moore, WJ Tyler, M Chigerwe, ME Dawes, JR Middleton: Effect of delayed colostrum collection on colostral IgG concentration in dairy cows. J Am Vet Med Assoc 226(8), 1375–7 (2005)

  • [15]AK Dang, S Kapila, MPC Singh: Changes in colostrum of Murrah buffaloes after calving. Trop Anim Health Prod 41(7), 1213–7 (2009)

  • [16]H Korhonen, A Pihlanto: Technological options for the production of health-promoting proteins and peptides derived from milk and colostrums. Curr Pharm Des 13(8), 829-43 (2007)

  • [17]BL Larson, HL Jr Heary, JE Devery: Immunoglobulin production and transport by the mammary gland. J Dairy Sci 63(4), 665-71 (1980)

  • [18]EM Lilius, P. Marnila: The role of colostral antibodies in prevention of microbial infections. Curr Opin Infect Dis 14(3), 295-300 (2001)

  • [19]R Mehra, P Marnila, H Korhonen: Milk immunoglobulins for health promotion. Int Dairy J 16(11), 1262–71 (2006)

  • [20]JK Sponseller, JA Steele, DJ Schmidt, HB Kim, G Beamer, X Sun, S Tzipori: Hyperimmune Bovine Colostrum as a Novel Therapy to Combat Clostridium difficile Infection. J Infect Dis 211(8), 1334-41 (2015)

  • [21]S Hiss, T Meyer, H Sauerwein: Lactoferrin concentrations in goat milk throughout lactation. Small Rumin Res 80(1-3), 87–90 (2008)

  • [22]D Legrand, E Elass, M Carpentier, J Mazurier: Lactoferrin: a modulator of immune and inflammatory responses. Cell Nol Life Sci 62(22), 2549-59 (2005)

  • [23]N Anand, RK Kanwar, ML Dubey, RK Vahishta, R Sehgal, AK Verma, JR Kanwar: Effect of lactoferrin protein on red blood cells and macrophages: mechanism of parasite-host interaction. Drug Des Devel Ther 9, 821-35 (2015)

  • [24]MM Rahman, WS Kim, T Ito, H Kumura, K Shimazaki: Growth promotion and cell binding ability of bovine lactoferrin to Bifidobacterium longum. Anaerobe 15(4), 133-7 (2009)

  • [25]V Buccigrossi, G de Marco, E Bruzzese, Ombrato L, I Bracale, G Polito, Guarino A: Lactoferrin induces concentration-dependent functional modulation of intestinal proliferation and differentiation. Pediatr Res 61(4), 410-4 (2007)

  • [26]J Artym, M Zimecki: Milk-derived proteins and peptides in clinical trials. Postepy Hig Med Dosw (Online) 67, 800-16 (2013)

  • [27]J Przybylska, E Albera, M Kankofer: Antioxidants in bovine colostrum. Reprod Domest Anim 42(4), 402-9 (2007)

  • [28]L Ahmed, SK Nazul Islam, MNI Khan, S Huque, M Ashan: Antioxidant micronutrient profile (vitamin E, C, A, Cooper, Zinc, Iron) of colostrums: association with maternal characteristics. J Trop Pediatr 50(6), 357–8 (2004)

  • [29]A Belo, T Marchbank, A Fitzgerald, S Ghosh, RJ Playford: Gastroprotective effects of oral nucleotide administration. Gut 55(2), 165-71 (2006)

  • [30]WH Yu: Scientific rationale and benefits of nucleotide supplementation of infant formula. J Paediatr Child Health 38(6), 543–9 (2002)

  • [31]XL Pan, T Izumi: Variation of the ganglioside compositions of human milk, cow’s milk and infant formulas. Early Hum Dev 57(1), 25–31 (2000)

  • [32]R Rueda: The role of dietary gangliosides on immunity and the prevention of infection. Br J Nutr 98 (Suppl 1), 68-73 (2007)

  • [33]T Idot, H Kawakami: Inhibitory effects of milk gangliosides on the adhesion of escherichia coli to human intestinal carcinoma cells. Biosci Biotech Biochem 59(1), 69–72 (1995)

  • [34]T Nakano, M Sugawara, H Kawakami: Sialic acid in human milk: composition and functions. Acta Paediatr Taiwan 42(1), 11-7 (2001)

  • [35]T Urashima, E Taufik, K Fukuda, S Asakuma: Recent advances in studies on milk oligosaccharides of cows and other domestic farm animals. Biosci Biotechnol Biochem 77(3), 455-66 (2013)

  • [36]T Urashima, K Fukuda, M Messer: Evolution of milk oligosaccharides and lactose: a hypothesis. Animal 6(3), 369-74 (2012)

  • [37]DS Newburg: Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. J Anim Sci 87 (Suppl 13), 26-34 (2009)

  • [38]H Tlaskalová-Hogenová, R Štepánková, T Hudcovic, L Tucková, B Cukrowska, R Lodinová-Žádnıková: Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett 93, (2-3), 97–108 (2004)

  • [39]S Jara, M Sánchez, R Vera, J Cofré, E Castro: The inhibitory activity of Lactobacillus spp. isolated from breast milk on gastrointestinal pathogenic bacteria of nosocomial origin. Anaerobe 17(6), 474-7 (2011)

  • [40]A Sokolowska, R Bednarz, M Pacewicz, JA Georgiades, T Wilusz, A Polanowski: Colostrum from different mammalian species—A rich source of colostrinin. Int Dairy J 18(2), 204–9 (2008)

  • [41]M Janusz, J Lisowski: Proline-rich polypeptide (PRP)—an immunomodulatory peptide from bovine colostrums. Arch Immun Et Ther Exper 41(5-6), 275–9 (1993)

  • [42]I Boldogh, L Aguilera-Aguirre, A Bacsi, BK Choudhury, A Saavedra-Molina, M Kruzel: Colostrin decreases hypersensitivity and allergic responses to common allergens. Int Arch Allergy Immunol 146(4), 298-306 (2008)

  • [43]MG Stewart: New insight into mode of action of Colostrinin. J Nutr Health Aging 14(4), 336 (2010)

  • [44]A Zabłocka, A Ogorzałek, J Macała, M Janusz: A proline-rich polypeptide complex (PRP) influences inducible nitric oxide synthase in mice at the protein level. Nitric Oxide 23(1), 20-5 (2010)

  • [45]M Janusz, A Zabłocka: Colostral proline-rich polypeptides--immunoregulatory properties and prospects of therapeutic use in Alzheimer’s disease. Curr Alzheimer Res 7(4), 323-33 (2010)

  • [46]A Bacsi, GJ Stanton, TK Hughes, M Kruzel, I Boldogh: Colostrinin-driven neurite outgrowth requires p53 activation in PC12 cells. Cell Mol Neurobiol 25(7), 1123–39 (2005)

  • [47]DA Camfield, L Owen, AB Scholey, A Pipingas, C Stough: Dairy constituents and neurocognitive health in ageing. Br J Nutr 106(2), 159-74 (2011)

  • [48]R Garofalo: Cytokines in human milk. J Pediatr 156 (Suppl 2), 36-40 (2010)

  • [49]K Hagiwara, S Kataoka, H Yamanaka, R Kirisawa, H Iwai: Detection of cytokines in bovine colostrums. Vet Immunol Immunopathol 76(3-4), 183-90 (2000)

  • [50]MM Sira, T Yoshida, M Takeuchi, Y Kashiwayama, T Futatani, H Kanegane, A Sasahara, Y Ito, M Mizuguchi, T Imanaka, T Miyawaki: A novel immunoregulatory protein in human colostrum, syntenin-1, for promoting the development of IgA-producing cells from cord blood B cells. Int Immunol 21(9), 1013-23 (2009)

  • [51]CM Shing, JM Peake, K Suzuki, DG Jenkins, JS Coombes: Bovine colostrum modulates cytokine production in human peripheral blood mononuclear cells stimulated with lipopolysaccharide and phytohemagglutinin. J Interferon Cytokine Res 29(1), 37-44 (2009)

  • [52]DC Donovan, AJ Reber, J Gabbard, M Aceves-Avila, KL Galland, K Holbert, LO Ely, DJ Hurley: Effect of maternal cells transferred with colostrum on cellular responses to pathogen antigens in neonatal calves. Am J Vet Res 68(7), 778–82 (2007)

  • [53]AJ Reber, DC Donovan, J Gabbard, K Galland, M Aceves-Avila, KA Holbert, L Marshall, DJ Hurley: Transfer of maternal colostral leukocytes promotes development of the neonatal immune system I. Effects on monocyte lineage cells. Vet Immunol Immunopathol 123(3-4), 186–96 (2008)

  • [54]JF Kuemmerle: Insulin-like growth factors in the gastrointestinal tract and liver. Endocrinol Metab Clin North Am 41(2), 409-23 (2012)

  • [55]JW Blum, CR Baumrucker: Colostral insulin-like growth factors and related substances: mammary gland, and neonatal (intestinal and systemic) targets. Domest Anim Endocrinol 23(1-2), 101–10 (2002)

  • [56]PM Jehle, RD Fussgaenger, WF Blum, NK Angelus, A Hoeflich, E Wolf, RJ Jungwirth: Differential autocrine regulation of intestinal epithelial cell proliferation and differentiation by insulin-like growth factor (IGF) system component. Horm Metab Res 31(2-3), 97–102 (1999)

  • [57]M Good, CP Sodhi, CE Egan, A Afrazi, H Jia, Y Yamaguchi, P Lu, MF Branca, C Ma, T Jr Prindle, S Mielo, A Pompa, Z Hodzic, JA Ozolek, DJ Hackam: Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor. Mucosal Immunol 8(5), 1166-79 (2015)

  • [58]JF Thompson, M Van Den Berg, PCF Stokkers: Developmental regulation of epidermal growth factor receptor kinase in rat intestine. Gastroenterology 107(5), 1278–87 (1994)

  • [59]H Okuyama, M Urao, D Lee, RA Drongowski, AG Coran: The effect of epidermal growth factor on bacterial translocation in newborn rabbits. J Pediatr Surg 33(2), 225–8 (1998)

  • [60]SA Cartlidge, JB Elder: Transforming growth factor α and EGF levels in normal human gastrointestinal mucosa. Br J Cancer 60(5), 657–60 (1989)

  • [61]S Koyama, DK Podolsky: Differential expression of transforming growth factors α and β in rat intestinal epithelial cells. J Clin Invest 83(5), 1768–73 (1989)

  • [62]DN Nguyen, PT Sangild, MV Ostergaard, SB Bering, DE Chatterton: Transforming growth factor-β2 and endotoxin interact to regulate homeostasis via interleukin-8 levels in the immature intestine. Am J Physiol Gastrointest Liver Physiol 307(7), 689-99 (2014)

  • [63]J Ogawa, A Sasahara, T Yoshida, MM Sira, T Futatani, H Kanegane, T Miyawaki: Role of transforming growth factor-beta in breast milk for initiation of IgA production in newborn infants. Early Hum Dev 77(1-2), 67–75 (2004)

  • [64]YW Shing, M Klagsbrun: Human and bovine milk contain different sets of growth factors. Endocrinology 115(1), 273–82 (1984)

  • [65]PJ Keck, SD Hauser, G Krivi, K Sanzo, T Warren, J Feder, DT Connolly: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246 (4935), 1309–12 (1989)

  • [66]CG Siafakas, F Anatolitou, RD Fusunyan, WA Walker, IR Sanderson: Vascular endothelial growth factor (VEGF) is present in human breast milk and its receptor is present on intestinal epithelial cells. Pediatr Res 45(5 Pt 1), 652–7 (1999)

  • [67]P Rawal, V Gupta, BR Thapa: Role of colostrum in gastrointestinal infections. Indian J Pediatr 75(9), 917-21 (2008)

  • [68]RJ Playford, CE Macdonald, WS Johnson: Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders. Am J Clin Nutr 72(1), 5-14 (2000)

  • [69]BR Thapa: Therapeutic potentials of bovine colostrums. Indian J Pediatr 72(10), 849-52 (2005)

  • [70]M Blais, M Fortier, Y Pouliot, SF Gauthier, Y Boutin, C Asselin, M Lessard: Colostrum whey down-regulates the expression of early and late inflammatory response genes induced by Escherichia coli and Salmonella enterica Typhimurium components in intestinal epithelial cells. Br J Nutr 113(2), 200-11 (2014)

  • [71]I Shibata, M Ono, M Mori: Passive protection against porcine epidemic diarrhea (PED) virus in piglets by colostrum from immunized cows. J Vet Med Sci 63(6), 655-8 (2001)

  • [72]G Günaydın, R Zhang, L Hammarström, H Marcotte: Engineered Lactobacillus rhamnosus GG expressing IgG-binding domains of protein G: Capture of hyperimmune bovine colostrum antibodies and protection against diarrhoea in a mouse pup rotavirus infection model. Vaccine 32(4), 470-7 (2014)

  • [73]M Inagaki, H Muranishi, K Yamada, K Kakehi, K Uchida, T Suzuki, T Yabe, T Nakagomi, O Nakagomi, Y Kanamaru: Bovine κ-casein inhibits human rotavirus (HRV) infection via direct binding of glycans to HRV. J Dairy Sci 97(5), 2653-61 (2014)

  • [74]M Inagaki, M Yamamoto, Cairangzhuoma Xijier, T Yabe, K Uchida, M Kawasaki, T Nakagomi, O Nakagomi, N Minamoto, Y Kanamaru: Multiple-dose therapy with bovine colostrum confers significant protection against diarrhea in a mouse model of human rotavirus-induced gastrointestinal disease. J Dairy Sci 96(2), 806-14 (2013)

  • [75]AK Mitra, D Mahalanabis, H Ashraf, L Unicomb, R Eeckels, S Tzipori: Hyperimmune cow colostrum reduces diarrhoea due to rotavirus: a double-blind, controlled clinical trial. Acta Paediatr 84(9), 996-1001 (1995)

  • [76]GP Davidson, PB Whyte, E Daniels, K Franklin, H Nunan, PI McCloud, AG Moore, DJ Moore: Passive immunization of children with bovine colostrum containing antibodies to human rotavirus. Lancet 2 (8665), 709-12 (1989)

  • [77]RB Turner, DK Kelsey: Passive immunization for prevention of rotavirus illness in healthy infants. Pediatr Infect Dis J 12(9), 718-22 (1993)

  • [78]H Hilpert, H Brüssow, C Mietens, J Sidoti, L Lerner, H Werchau: Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants. J Infect Dis 156(1), 158-66 (1987)

  • [79]D Durand, TJ Ochoa, SM Bellomo, CA Contreras, VH Bustamante, J Ruiz, TG Cleary: Detection of secretory immunoglobulin A in human colostrum as mucosal immune response against proteins of the typeIII secretion system of Salmonella, Shigella and enteropathogenic Escherichia coli. Pediatr Infect Dis J 32(10), 1122-6 (2013)

  • [80]W Otto, B Najnigier, T Stelmasiak, RM Robins-Browne: Randomized control trials using a tablet formulation of hyperimmune bovine colostrum to prevent diarrhea caused by enterotoxigenic Escherichia coli in volunteers. Scand J Gastroenterol 46(7-8), 862-8 (2011)

  • [81]CP Champagne, Y Raymond, Y Pouliot, SF Gauthier, M Lessard: Effect of bovine colostrum, cheese whey, and spray-dried porcine plasma on the in vitro growth of probiotic bacteria and Escherichia coli. Can J Microbiol 60(5), 287-95 (2014)

  • [82]DA Vilte, M Larzábal, AA Cataldi, EC Mercado: Bovine colostrum contains immunoglobulin G antibodies against intimin, EspA, and EspB and inhibits hemolytic activity mediated by the type three secretion system of attaching and effacing Escherichia coli. Clin Vaccine Immunol 15(8), 1208-13 (2008)

  • [83]S Sugiharto, AS Poulsen, N Canibe, C Lauridsen: Effect of bovine colostrum feeding in comparison with milk replacer and natural feeding on the immune responses and colonisation of enterotoxigenic Escherichia coli in the intestinal tissue of piglets. Br J Nutr 113(6), 923-34 (2015)

  • [84]HI Tawfeek, NH Najim, S Al-Mashikhi: Efficacy of an infant formula containing anti-Escherichia coli colostral antibodies from hyperimmunized cows in preventing diarrhea in infants and children: a field trial. Int J Infect Dis 7(2), 120-8 (2003)

  • [85]CO Tacket, G Losonsky, H Link, Y Hoang, P Guesry, H Hilpert, MM Levine: Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. N Engl J Med 318(19), 1240-3 (1988)

  • [86]DJ Freedman, CO Tacket, A Delehanty, DR Maneval, J Nataro, JH Crabb: Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli. J Infect Dis 177(3), 662-7 (1998)

  • [87]DM Lyerly, EF Bostwick, SB Binion, TD Wilkins: Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate. Infect Immun 59(6), 2215-8 (1991)

  • [88]E Mattila, VJ Anttila, M Broas, H Marttila, P Poukka, K Kuusisto, L Pusa, K Sammalkorpi, J Dabek, OP Koivurova, M Vähätalo, V Moilanen, T Widenius: A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: efficacy and safety data of a prematurely interrupted trial. Scand J Infect Dis 40(9), 702-8 (2008)

  • [89]P Naaber, E Lehto, S Salminen, M Mikelsaar: Inhibition of adhesion of Clostridium difficile to Caco-2 cells. FEMS Immunol Med Microbiol 14(4), 205-9 (1996)

  • [90]C Akisu, U Aksoy, H Cetin, S Ustun, M Akisu: Effect of human milk and colostrum on Entamoeba histolytica. World J Gastroenterol 10(5), 741-742 (2004)

  • [91]PC Okhuysen, CL Chappell, J Crabb, LM Valdez, ET Douglass, HL DuPont: Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum. Clin Infect Dis 26(6), 1324–29 (1998)

  • [92]S Tzipori, D Roberton, DA Cooper, L White: Chronic cryptosporidial diarrhoea and hyperimmune cow colostrums. Lancet 2 (8554), 344-5 (1987)

  • [93]PD Greenberg, JP Cello: Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 13(4), 348-54 (1996)

  • [94]S Purup, MO Vestergaard, L Pedersen, K Sejrsen: Biological activity of bovine milk on proliferation of human intestinal cells. J Dairy Res 74(1), 58–65 (2007)

  • [95]KS Chattha, AN Vlasova, S Kandasamy, MA Esseili, C Siegismund, G Rajashekara, LJ Saif: Probiotics and colostrum/milk differentially affect neonatal humoral immune responses to oral rotavirus vaccine. Vaccine 31(15), 1916-23 (2013)

  • [96]XH Huang, L Chen, W Gao, W Zhang, SJ Chen, LB Xu, SQ Zhang: Specific IgG activity of bovine immune milk against diarrhea bacteria and its protective effects on pathogen-infected intestinal damages. Vaccine 26(47), 5973–5980 (2008)

  • [97]J Seifert, M Molkewehrum, S Oesser, L Nebermann, C Schulze: Endotoxin inactivation by enterally applied colostrum of different composition. Eur Surg Res 34(1-2), 68-72 (2002)

  • [98]EB Wong, JF Mallet, J Duarte, C Matar, BW Ritz: Bovine colostrum enhances natural killer cell activity and immune response in a mouse model of influenza infection and mediates intestinal immunity through toll-like receptors 2 and 4. Nutr Res 34(4), 318-25 (2014)

  • [99]MJ An, JH Cheon, SW Kim, JJ Park, CM Moon, SY Han, ES Kim, TI Kim, WH Kim: Bovine colostrum inhibits nuclear factor kappa B-mediated proinflammatory cytokine expression in intestinal epithelial cells. Nutr Res 29(4), 275-80 (2009)

  • [100]D Cardani: COLOSTRO NONI administration effects on epithelial cells turn-over, inflammatory events and integrity of intestinal mucosa junctional systems. Minerva Gastroenterol Dietol 60(1), 71-8 (2014)

  • [101]R Neiger, KW Simpson: Helicobacter infection in dogs and cats: Facts and fiction. J Vet Intern Med 14(2), 125–133 (2000)

  • [102]AA Dos Santos, AA Carvalho: Pharmacological therapy used in the elimination of Helicobacter pylori infection: A review. World J Gastroenterol 21(1), 139-154 (2015)

  • [103]P Marnila, S Rokka, L Rehnberg-Laiho, P Kärkkäinen, TU Kosunen, H Rautelin, ML Hänninen, EL Syväoja, H Korhonen: Prevention and suppression of Helicobacter felis infection in mice using colostral preparation with specific antibodies. Helicobacter 8(3), 192-201 (2003)

  • [104]CD Tran, S Kritas, MA Campbell, HQ Huynh, SS Lee, RN Butler: Novel combination therapy for the eradication of Helicobacter pylori infection in a mouse model. Scand J Gastroenterol 45(12), 1424-30 (2010)

  • [105]MM Bitzan, BD Gold, DJ Philpott, M Huesca, PM Sherman, H Karch, R Lissner, CA Lingwood, MA Karmali: Inhibition of Helicobacter pylori and Helicobacter mustelae binding to lipid receptors by bovine colostrums. J Infect Dis 177(4), 955-61 (1998)

  • [106]S Rokka, S Myllykangas, V Joutsjoki: Effect of specific colostral antibodies and selected lactobacilli on the adhesion of Helicobacter pylori on AGS cells and the Helicobacter-induced IL-8 production. Scand J Immunol 68(3), 280-6 (2008)

  • [107]TH Casswall, HO Nilsson, L Björck, S Sjöstedt, L Xu, CK Nord, T Borén, T Wadström, L Hammarström: Bovine anti-Helicobacter pylori antibodies for oral immunotherapy. Scand J Gastroenterol 37(12), 1380-5 (2002)

  • [108]ML Xu, HJ Kim, HJ Kim: Effect of dietary bovine colostrum on the responses of immune cells to stimulation with bacterial lipopolysaccharide. Arch Pharm Res 37(4), 494-500 (2014)

  • [109]S Tarpila, H Korhonen, S Salminen: Immune Colostrums in the Treatment of Helicobacter Pylori Gastritis. In: Abstract book of 24th International Dairy Congress, Melbourne, Australia, 293 (1995)

  • [110]M Oona, T Rago, HI Maaroos: Helicobacter pylori in children with abdominal complaints: has immune colostrum some influence on gastritis? Alpe Adria Microbiology J 6, 49-57 (1997)

  • [111]AR Opekun, HM El-Zaimaity, MS Osato, MA Gilger, HM Malaty, M Terry, DR Headon, DY Graham: Novel therapies for Helicobacter pylori infection. Aliment Pharmacol Ther 13(1), 35-42 (1999)

  • [112]TH Casswall, SA Sarker, MJ Albert, GJ Fuchs, M Bergström, L Björck, L Hammarström: Treatment of Helicobacter pylori infection in infants in rural Bangladesh with oral immunoglobulins from hyperimmune bovine colostrum. Aliment Pharmacol Ther 12(6), 563-8 (1998)

  • [113]J Steele, J Sponseller, D Schmidt, O Cohen, S Tzipori: Hyperimmune bovine colostrum for treatment of GI infections: a review and update on Clostridium difficile. Hum Vaccin Immunother 9(7), 1565-8 (2013)

  • [114]ST Sonis: The pathobiology of mucositis. Nat Rev Cancer 4(4), 277-84 (2004)

  • [115]MJ van Vliet, WJ Tissing, CA Dun, NE Meessen, WA Kamps, ES de Bont, HJ Harmsen: Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin Infect Dis 49(2), 262-70 (2009)

  • [116]AM Stringer, RJ Gibson, JM Bowen, RM Logan, K Ashton, AS Yeoh, N Al-Dasooqi, DM Keefe: Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile. Int J Exp Pathol 90 (5), 489-99 (2009)

  • [117]GS Howarth, GL Francis, JC Cool, RW Ballard, LC Read: Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats. J Nutr 126(10), 2519-30 (1996)

  • [118]HY Chen, O Mollstedt, MH Tsai, RB Kreider: Potential clinical applications of multi-functional milk proteins and peptides in cancer management. Curr Med Chem 21(21), 2424-37 (2014)

  • [119]PE Pontoppidan, RL Shen, MS Cilieborg, P Jiang, H Kissow, BL Petersen, T Thymann, C Heilmann, K Müller, PT Sangild: Bovine Colostrum Modulates Myeloablative Chemotherapy-Induced Gut Toxicity in Piglets. J Nutr 145(7), 1472-80 (2015)

  • [120]ST Sonis, L Lindquist, A Van Vugt, AA Stewart, K Stam, GY Qu, KK Iwata, JD Haley: Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor beta 3. Cancer Res 54(5), 1135-8 (1994)

  • [121]GS Howarth, JC Cool, AJ Bourne, FJ Ballard, LC Read: Insulin-like growth factor-I (IGF-I) stimulates regrowth of the damaged intestine in rats, when administered following, but not concurrent with, methotrexate. Growth Factors 15(4), 279-292 (1998)

  • [122]NM Gordler, M McGurk, S Aqual, M Prince: The effect of epidermal growth factor mouthwash on cytotoxic-induced oral ulceration. Am J Clin Oncol 18(5), 403-6 (1995)

  • [123]DS Newburg, WA Walker: Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr Res 61(1), 2–8 (2007)

  • [124]M Cairangzhuoma, H Yamamoto, H Muranishi, M Inagaki, K Uchida, K Yamashita, S Saito, T Yabe, Y Kanamaru: Skimmed, sterilized, and concentrated bovine late colostrum promotes both prevention and recovery from intestinal tissue damage in mice. J Dairy Sci 96(3), 1347-55 (2013)

  • [125]AB Yaacov, Y Lichtenstein, L Zolotarov, Y Ilan: The gut microbiome as a target for regulatory T cell-based immunotherapy: induction of regulatory lymphocytes by oral administration of anti-LPS enriched colostrum alleviates immune mediated colitis. BMC Gastroenterol 15(1), 154-61 (2015)

  • [126]J Martin, SC Howard, A Pillai, P Vogel, AP Naren, S Davis, K Ringwald-Smith, K Buddington, RK Buddington: The weaned pig as a model for Doxorubicin-induced mucositis. Chemotherapy 60(1), 24-36 (2014)

  • [127]L Trepanier: Drug Interactions and Differential Toxicity of NSAIDs. In: ACVIM Proceedings (2002)

  • [128]UA Boelsterli, MR Redinbo, KS Saitta: Multiple NSAID-induced hits injure the small intestine: underlying mechanisms and novel strategies. Toxicol Sci 131(2), 654-67 (2013)

  • [129]M Hagiwara, K Kataoka, H Arimochi, T Kuwahara, Y Ohnishi: Role of unbalanced growth of gram-negative bacteria in ileal ulcer formation in rats treated with a nonsteroidal anti-inflammatory drug. J Med Invest 51(1-2), 43-51 (2004)

  • [130]RD Berg: Bacterial translocation from the gastrointestinal tract. Adv Exp Med Biol 473, 11-30 (1999)

  • [131]S Zhang, B Lü, GQ Chao, FM Chen, MY Chen, HQ Chen: The effects of milk and milk products on non-steroidal anti-inflammatory drug induced intestinal damage in rats. Zhonghua Nei Ke Za Zhi 50(9), 771-5 (2011)

  • [132]HS Choi, KH Jung, SC Lee, SV Yim, JH Chung, YW Kim, WK Jeon, HP Hong, YG Ko, CH Kim, KH Jang, SA Kang: Bovine colostrum prevents bacterial translocation in an intestinal ischemia/reperfusion-injured rat model. J Med Food 12(1), 37-46 (2009)

  • [133]R Mir, N Singh, G Vikram, RP Kumar, M Sinha, A Bhushan, P Kaur, A Srinivasan, S Sharma, TP Singh: The structural basis for the prevention of nonsteroidal antiinflammatory drug-induced gastrointestinal tract damage by the C-lobe of bovine colostrum lactoferrin. Biophys J 97(12), 3178-86 (2009)

  • [134]JW Kim, WK Jeon, JW Yun, DI Park, YK Cho, IK Sung, CI Sohn, BI Kim, JS Yeom, HS Park, EJ Kim, MS Shin: Protective effects of bovine colostrum on non-steroidal anti-inflammatory drug induced intestinal damage in rats. Asia Pac J Clin Nutr 14(1), 103-7 (2005)

  • [135]EA Reznikov, SS Comstock, C Yi, N Contractor, SM Donovan: Dietary bovine lactoferrin increases intestinal cell proliferation in neonatal piglets. J Nutr 144(9), 1401-8 (2014)

  • [136]RJ Playford, DN Floyd, CE Macdonald, DP Calnan, RO Adenekan, W Johnson, RA Goodlad, T Marchbank: Bovine colostrum is a health food supplement which prevents NSAID induced gut damage. Gut 44(5), 653-8 (1999)

  • [137]RJ Playford, CE MacDonald, DP Calnan, DN Floyd, T Podas, W Johnson, AC Wicks, O Bashir, T Marchbank: Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability. Clin Sci (Lond) 100(6), 627-33 (2001)

  • [138]JW Kim, WK Jeon, EJ Kim: Combined effects of bovine colostrum and glutamine in diclofenac-induced bacterial translocation in rat. Clin Nutr 24(5), 785-93 (2005)

  • [139]NA Feasey, P Healey, MA Gordon: Review article: the aetiology, investigation and management of diarrhoea in the HIV-positive patient. Aliment Pharmacol Ther 34(6), 587–603 (2011)

  • [140]L Elfstrand, CH Flóren: Management of chronic diarrhea in HIV-infected patients: current treatment options, challenges and future directions. HIV AIDS (Auckl) 2, 219–224 (2010)

  • [141]JA Rump, R Arndt, A Arnold, C Bendick, H Dichtelmüller, M Franke, EB Helm, H Jäger, B Kampmann, P Kolb: Treatment of diarrhoea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum. Clin Investig 70(7), 588-594 (1992)

  • [142]A Plettenberg, A Stoehr, HJ Stellbrink, H Albrecht, W Meigel: A preparation from bovine colostrum in the treatment of HIV-postive patients with chronic diarrhea. Clin Investig 71(1), 42-5 (1993)

  • [143]CH Floren, S Chinenye, L Elfstrand, C Hagman, I Ihse: ColoPlus, a new product based on bovine colostrum, alleviates HIV-associated diarrhoea. Scand J Gastroenterol 41(6), 682–6 (2006)

  • [144]FO Kaducu, SA Okia, G Upenytho, L Elfstrand, CH Florén: Effect of bovine colostrum-based food supplement in the treatment of HIV-associated diarrhea in Northern Uganda: a randomized controlled trial. Indian J Gastroenterol 30(6), 270-6 (2011)

  • [145]J Schmidt, MS Kuhlenschmidt: Microbial adhesion of Cryptosporidium parvum: identification of a colostrum-derived inhibitory lipid. Mol Biochem Parasitol 162(1), 32-9 (2008)

  • [146]M Naciri, R Mancassola, JM Reperant, O Canivez, B Quinque, P Yvore: Treatment of experimental ovine cryptosporidiosis with ovine or bovine hyperimmune colostrums. Vet Parasitol 53(3-4), 173-90 (1994)

  • [147]BE Sands: From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology 126(6), 1518-1532 (2004)

  • [148]M Cerquetella, A Spaterna, F Laus, B Tesei, G Rossi, E Antonelli, V Villanacci, G Bassotti: Inflammatory bowel disease in the dog: differences and similarities with humans. World J Gastroenterol 16(9), 1050-6 (2010)

  • [149]T Hisamatsu, T Kanai, Y Mikami, K Yoneno, K Matsuoka, T Hibi: Immune aspects of the pathogenesis of inflammatory bowel disease. Pharmacol Ther 137(3), 283-97 (2013)

  • [150]G Bouma, W Strober: The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3(7), 521–533 (2003)

  • [151]I Sekirov, SL Russell, LC Antunes, BB Finlay: Gut microbiota in health and disease. Physiol Rev 90 (3), 859-904 (2010)

  • [152]A Andoh, H Imaeda, T Aomatsu, O Inatomi, S Bamba, M Sasaki, Y Saito, T Tsujikawa, Y Fujiyama: Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn’s disease using terminal restriction fragment length polymorphism analysis. J Gastroenterol 46(4), 479-86 (2011)

  • [153]A Dignass, JO Lindsay, A Sturm, A Windsor, JF Colombel, M Allez, G D’Haens, A D’Hoore, G Mantzaris, G Novacek, T Oresland, W Reinisch, M Sans, E Stange, S Vermeire, S Travis, G Van Assche: Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part2: current management. J Crohns Colitis 6(10), 991-1030 (2012)

  • [154]M Bellavia F Rappa, M Lo Bello, G Brecchia, G Tomasello, A Leone, G Spatola, ML Uzzo, G Bonaventura, S David, P Damiani, I Hajj Hussein, MN Zeenny, A Jurjus, P Schembri-Wismayer, M Cocchi, G Zummo, F Farina, A Gerbino, F Cappello, G Traina: Lactobacillus casei and bifidobacterium lactis supplementation reduces tissue damage of intestinal mucosa and liver after 2,4,6-trinitrobenzenesulfonic acid treatment in mice. J Biol Regul Homeost Agents 28(2), 251-61 (2014)

  • [155]P Bodammer, C Maletzki, G Waitz, J Emmrich: Prophylactic application of bovine colostrum ameliorates murine colitis via induction of immunoregulatory cells. J Nutr 141(6), 1056-61 (2011)

  • [156]P Bodammer, E Zirzow, S Klammt, C Maletzki, C Kerkhoff: Alteration of DSS-mediated immune cell redistribution in murine colitis by oral colostral immunoglobulin. BMC Immunol 14, 10-8 (2013)

  • [157]Z Khan, C Macdonald, AC Wicks, MP Holt, D Floyd, S Ghosh, NA Wright, RJ Playford: Use of the ‘nutriceutical’, bovine colostrum, for the treatment of distal colitis: results from an initial study. Aliment Pharmacol Ther 16(11), 1917-22 (2002)

  • [158]P Bodammer, C Kerkhoff, C Maletzki, G Lamprecht: Bovine colostrum increases pore-forming claudin-2 protein expression but paradoxically not ion permeability possibly by a change of the intestinal cytokine milieu. PLoS One 8(5), 64210 (2013)

  • [159]M Petrosyan, YS Guner, M Williams, A Grishin, HR Ford: Current concepts regarding the pathogenesis of necrotizing enterocolitis. Pediatric Surgery International 25(4), 309–18 (2009)

  • [160]RH Siggers, J Siggers, T Thymann, M Boye, PT Sangild: Nutritional modulation of the gut microbiota and immune system in preterm neonates susceptible to necrotizing enterocolitis. J Nutr Biochem 22(6), 511-21 (2011)

  • [161]DA Kelly: Intestinal failure-associated liver disease: what do we know today?. Gastroenterology 130(2 Suppl 1), 70–7 (2006)

  • [162]RJ Xu, F Wang, SH Zhang: Postnatal adaptation of the gastrointestinal tract in neonatal pigs: a possible role of milk-borne growth factors. Livest Prod Sci 66(2), 95–107 (2000)

  • [163]ER Van Haver, PT Sangild, M Oste, JL Siggers, AL Weyns, CJ Van Ginneken: Diet dependent mucosal colonization and interleukin-1beta responses in preterm pigs susceptible to necrotizing enterocolitis. J Pediatr Gastroenterol Nutr 49(1), 90–8 (2009)

  • [164]MS Cilieborg, M Boye, L Mølbak, T Thymann, PT Sangild: Preterm birth and necrotizing enterocolitis alter gut colonization in pigs. Pediatr Res 69(1), 10-6 (2011)

  • [165]SM Gephart, M Weller: Colostrum as oral immune therapy to promote neonatal health. Adv Neonatal Care 14(1), 44-51 (2014)

  • [166]MP Sherman, MM Miller, J Sherman, V Niklas: Lactoferrin and necrotizing enterocolitis. Curr Opin Pediatr 26(2), 146-50 (2014)

  • [167]Y Li, ML Jensen, DE Chatterton, BB Jensen, T Thymann, AS Kvistgaard, PT Sangild: Raw bovine milk improves gut responses to feeding relative to infant formula in preterm piglets. Am J Physiol Gastrointest Liver Physiol 306(1), 81-90 (2014)

  • [168]ML Jensen, PT Sangild, M Lykke, M Schmidt, M Boye, BB Jensen, T Thymann: Similar efficacy of human banked milk and bovine colostrum to decrease incidence of necrotizing enterocolitis in preterm piglets. Am J Physiol Regul Integr Comp Physiol 305(1), 4-12 (2013)

  • [169]NA Rodriguez, M Vento, EC Claud, CE Wang, MS Caplan: Oropharyngeal administration of mother’s colostrum, health outcomes of premature infants: study protocol for a randomized controlled trial. Trials 16(1), 453-66 (2015)

  • [170]HK Moller, T Thymann, LN Fink, H Frokiaer, AS Kvistgaard, PT Sangild: Bovine colostrum is superior to enriched formulas in stimulating intestinal function and necrotising enterocolitis resistance in preterm pigs. Br J Nutr 105(1), 44–53 (2011)

  • [171]HJ Brooks, MA McConnell, J Corbett, GS Buchan, CE Fitzpatrick, RS Broadbent: Potential prophylactic value of bovine colostrum in necrotizing enterocolitis in neonates: an in vitro study on bacterial attachment, antibody levels and cytokine production. FEMS Immunol Med Microbiol 48(3), 347-54 (2006)

  • [172]AC Støy, PM Heegaard, T Thymann, M Bjerre, K Skovgaard, M Boye, B Stoll, M Schmidt, BB Jensen, PT Sangild: Bovine colostrum improves intestinal function following formula-induced gut inflammation in preterm pigs. Clin Nutr 33(2), 322-9 (2014)

  • [173]M Pammi, SA Abrams: Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2, CD007137 (2015)

  • [174]PT Sangild, RH Siggers, M Schmidt, J Elnif, CR Bjornvad, T Thymann, ML Grondahl, AK Hansen, SK Jensen, M Boye, L Moelbak, RK Buddington, BR Weström, JJ Holst, DG Burrin: Diet-and colonization-dependent intestinal dysfunction predisposes to necrotizing enterocolitis in preterm pigs. Gastroenterology 130(6), 1776-92 (2006)

  • [175]J Lee, HS Kim, YH Jung, KY Choi, SH Shin, EK Kim, JH Choi: Oropharyngeal colostrum administration in extremely premature infants: an RCT. Pediatrics 135(2), 357-66 (2015)

  • [176]PM Pereira-Fantini, SL Thomas, RG Taylor, E Nagy, M Sourial, PJ Fuller, JE Bines: Colostrum supplementation restores insulin-like growth factor -1 levels and alters muscle morphology following massive small bowel resection. J Parenter Enteral Nutr 32(3), 266-75 (2008)

  • [177]ES Nagy, MC Paris, RG Taylor, PJ Fuller, M Sourial, F Justice, JE Bines: Colostrum protein concentrate enhances intestinal adaptation after massive small bowel resection in juvenile pigs. J Pediatr Gastroenterol Nutr 39(5), 487-92 (2004)

  • [178]P Lund, PT Sangild, L Aunsholt, B Hartmann, JJ Holst, J Mortensen, PB Mortensen, PB Jeppesen: Randomised controlled trial of colostrum to improve intestinal function in patients with short bowel syndrome. Eur J Clin Nutr 66(9), 1059-654 (2012)

  • [179]D Kelly, TP King, M McFadyen, AGP Coutts: Effect of preclosure colostrum intake on the development of the intestinal epithelium of artificially reared piglets. Biol Neonate 64(4), 235–44 (1993)

  • [180]W O’Loughlin, M Winter, A Shun, JA Hardin, DG Gall: Structural and functional adaptation following jejunal resection in rabbits: effect of epidermal growth factor. Gastroenterology 107(1), 87-93 (1994)

  • [181]JW Alexander, ST Boyce, GF Babcock, L Gianotti, MD Peck, DL Dunn, T Pyles, CP Childress, SK Ash: The process of microbial translocation. Ann Surg 212(4), 496–510 (1990)

  • [182]H Tsujimoto, S Ono, H Mochizuki: Role of translocation of pathogen-associated molecular patterns in sepsis. Dig Surg 26(2), 100-9 (2009)

  • [183]E Bolke, PM Jehle, F Hausmann, A Däubler, H Wiedeck, G Steinbach, M Storck, K Orth: Preoperative oral application of immunoglobulin-enriched colostrum milk and mediator response during abdominal surgery. Shock 17(1), 9-12 (2002)

  • [184]E Bolke, K Orth, PM Jehle, A Schwarz, G Steinbach, S Schleich, C Ulmer, M Storck, A Hannekum: Enteral application of an immunoglobulin-enriched colostrum milk preparation for reducing endotoxin translocation and acute phase response in patients undergoing coronary bypass surgery – a randomized placebo controlled pilot trial. Wien Klin Wochenschr 114(21-22), 923-8 (2002)

  • [185]JR Döhler, L Nebermann: Bovine colostrum in oral treatment of enterogenic endotoxaemia in rats. Crit Care 6(6), 536-9 (2002)

  • [186]LL Go, CT Albanese, SC Watkins, RL Simmons, MI Rowe: Breast milk protects the neonate from bacterial translocation. J Pediatr Surg 29(8), 1059-63 (1994)

  • [187]R Lissner, H Schmidt, H Karch: A standard immunoglobulin preparation produced from bovine colostra shows antibody reactivity and neutralization activity against Shiga-like toxins and EHEC-hemolysin of Escherischia coli 0157:H7. Infection 24(5), 378-383 (1996)

  • [188]AY Kshirsagar, MA Vekariya, V Gupta, AS Pednekar, A Mahna, R Patankar, A Shaikh, B Nagur: A comparative study of colostrum dressing versus conventional dressing in deep wounds. J Clin Diagn Res 9(4), 1-4 (2015)

  • [189]PF Davis, NS Greenhill, AM Rowan, LM Schollum: The safety of New Zealand bovine colostrum: Nutritional and physiological evaluation in rats. Food Chem Toxicol 45(2), 229–36 (2007)

  • [190]WG Struff, G Sprotte: Bovine colostrum as a biologic in clinical medicine: a review – Part II: clinical studies. Int J Clin Pharmacol Ther 46(5), 211–225 (2008)

  • [191]S Tsabouri, K Douros, KN Priftis: Cow’s milk allergenicity. Endocr Metab Immune Disord Drug Targets 14(1), 16-26 (2014)

Article Metrics

  • Information

  • Download

  • Contents

Frontiers in Bioscience-Scholar (FBS) is published by IMR Press from Volume 13 Issue 1 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

1 Jun 2016Review

Potential benefits of colostrum in gastrointestinal diseases

Laura Menchetti 1, Giovanna Traina 2, Giovanni Tomasello 3,4, Patrizia Casagrande-Proietti 1, Leonardo Leonardi 1, Olimpia Barbato 1, Gabriele Brecchia 1,*
Affiliations
Article Info

1 Department of Veterinary Medicine, University of Perugia, via S. Costanzo 4, Perugia, Italy

2 Department of Pharmaceutical Sciences, University of Perugia, Via S. Costanzo, Perugia, Italy

3 Euro-Mediterranean Institute of Science and Technology (IEMEST), Via E. Amari 123, Palermo, Italy

4 DICHIRONS Department, University of Palermo, Via L. Giuffre 5, Palermo, Italy

*Author to whom correspondence should be addressed.

 

Abstract

This paper reviews the composition of colostrum and the potential preventive and therapeutic use of this “first milk” for treating various gastrointestinal disorders in humans. Colostrum is a complex biological liquid that is richer in antimicrobial peptides, immune-regulating compounds and growth factors than the subsequent mature milk. The main functions of colostrum are to provide essential nutritional components, strengthen the natural defense system, modulate immune response, balance intestinal microbiota and enhance the growth and repair of several tissues. Several studies and clinical trials carried out both in vitro and in vivo on humans and animals suggest the clinical benefits of bovine colostrum (BC) supplementation in gastro-intestinal diseases. Despite the encouraging results, further well-designed studies are required in order to confirm these effects, the dose and duration of treatment. Colostrum is safe since there are no contraindications regarding high dose levels and few side effects of clinical relevance have been reported. In conclusion, in the near future, colostrum-based supplements may play a complementary role to synthetic drugs in the prevention and treatment of various gastrointestinal disorders.

Keywords

  • Colostrum
  • Anti-Microbical Factors
  • Immunity
  • Growth Factors
  • Intestinal Disorders
  • Review

References